Nktx stock forecast.

TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the ...We would like to show you a description here but the site won’t allow us.Apr 25, 2022 · On today's stock market, the biotech stock soared 140.9% to 18.72. After the close, Nkarta announced a public offering for $150 million shares of its common stock. 14,305.03 +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Nkarta, Inc. (NKTX) NasdaqGS - NasdaqGS Real Time Price....

View real-time stock prices and stock quotes for a full financial overview. ... AMC Stock Outlook: Billionaire Bails, But Does a Comeback Beckon? May. 24, 2023 at 1:20 p.m. ET ...The above table shows the analyst NKTX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$2.64 May 3, 2021 · NKTX : Nkarta stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis

Track Nkarta Inc (NKTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $68.19M. -89.4%. Market Cap / Employee. The market cap of a ...Oct 11, 2023 · An investor can expect a potential return of 1007.01% based on the average NKTX price forecast. Analyzing the NKTX fundamentals To continue investigating profitability, this company’s Return on Assets is posted at -30.48, Equity is -36.53, Total Capital is -33.11, and Invested Capital is -31.98. About the Nkarta, Inc. stock forecast. As of 2023 October 17, Tuesday current price of NKTX stock is 1.495$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).Nov 15, 2023 · Analysts are generally bullish on Nkarta’s long-term prospects, but they are divided on how high the stock price could go in 2023. Some analysts believe that the stock could reach $20 or even $30 per share, while others believe that it is more likely to trade in the $10-$15 range. Ultimately, how high NKTX will go in 2023 is a matter of ... Wall Street Stock Market & Finance report, prediction for the future: You'll find the Seven Arts Entertainment share forecasts, stock quote and buy / sell signals below. According to present data Seven Arts Entertainment's SAPX shares and potentially its market environment have been in bearish cycle last 12 months (if exists).

According to the issued ratings of 5 analysts in the last year, the consensus rating for Nkarta stock is Buy based on the current 1 hold rating, 3 buy ratings and 1 strong buy rating for NKTX. The average twelve-month price prediction for Nkarta is $14.67 with a high price target of $26.00 and a low price target of $9.00.

Find the latest SEC Filings data for Nkarta, Inc. Common Stock (NKTX) at Nasdaq.com.

Be the first to know when Wall Street analysts revise their GSK stock forecasts and price targets. ... 3 Wall Street analysts forecast GSK's revenue for 2024 to be ...Price Target Based on short-term price targets offered by seven analysts, the average price target for Nkarta, Inc. comes to $12.57. The forecasts range from a low of $9.00 to a high of $15.00....1.43. -0.05. -3.72%. Get Nkarta Inc (NKTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Find the latest Institutional Holdings data for Nkarta, Inc. Common Stock (NKTX) at Nasdaq.com.Find the latest analyst research for Nkarta, Inc. Common Stock (NKTX) at Nasdaq.com.If you're new to stock investing, here's how to buy Exela Technologies stock. What is XELA's forecast return on assets (ROA) for 2023-2023? (NASDAQ: XELA) forecast ROA is -98.28%, which is lower than the forecast US Software - …NKTX Earnings Forecast. Next quarter’s earnings estimate for NKTX is -$0.59 with a range of -$0.96 to -$0.40. The previous quarter’s EPS was -$0.52. NKTX beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 59.59% of the time in the same period.

The consensus price target of analysts on Wall Street is $14.13, which implies an increase of 80.75% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $9.00 and $25.00 respectively. As a result, NKTX is trading at a discount of -819.12% off the target high and -230.88% off the low.US$296.82m. Market Cap. US$128.57m. NKTX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA. Key Statistics. Enterprise Value/Revenue. n/a. Enterprise Value/EBITDA.Forecast. NKTX technical analysis. This gauge displays a real-time technical ... Stock Screener · Forex Screener · Crypto Pairs Screener · Crypto Coins Screener ...Nov 30, 2023 · Price Target Based on short-term price targets offered by seven analysts, the average price target for Nkarta, Inc. comes to $12.57. The forecasts range from a low of $9.00 to a high of $15.00.... Nkarta (NKTX) is a clinical-stage biopharmaceutical company that develops and commercializes cell therapies for cancer treatment. The company's co-lead product candidates are NKX101 and NKX019, which are in phase I trials for various B cell …Jun 28, 2023 · June 28, 2023 at 9:35 AM · 2 min read. Nkarta, Inc. (NKTX) has been beaten down lately with too much selling pressure. While the stock has lost 39.3% over the past four weeks, there is light at ...

The 12-month stock price forecast is $13.0, which is an increase of 422.09% from the latest price. Price Target $13.0 ( 422.09% upside) Analyst Consensus: Strong Buy Stock Forecasts News All Videos Press Releases Conversation Nkarta Reports Third Quarter 2023 Financial Results and Corporate Highlights

Find real-time FSR - Fisker Inc stock quotes, company profile, news and forecasts from CNN Business.Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...On August 10, 2023, Nkarta, a company listed on NASDAQ under the ticker symbol NKTX, revealed its financial performance for Nkartas Financial Report Highlights Strong Liquidity and Positive Outlook - Best StocksFind the latest Evoke Pharma, Inc. (EVOK) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Jun 15, 2023 · (See NKTX stock forecast) To find good ideas for penny stocks trading at attractive valuations, visit TipRanks’ Penny Stock Screener. Disclaimer: The opinions expressed in this article are ... Nkarta, Inc. (NKTX) share price prediction for 2023, 2024, 2025, 2026 and 2027. NKTX one year forecast. Nkarta stock monthly and weekly forecasts.

Find the latest Nkarta, Inc. (NKTX) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears.

In 2022, GSK plc's revenue was 29.32 billion, an increase of 18.74% compared to the previous year's 24.70 billion. Earnings were 14.96 billion, an increase of 241.07%. Financial numbers in GBP Financial Statements.

NKTX Stock Price | Nkarta Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch Home Investing Quotes Stocks United States NKTX Overview Stock Screener Earnings Calendar Sectors Nasdaq |...Stock Price Forecast The 12 analysts offering 12-month price forecasts for C3.ai Inc have a median target of 27.50, with a high estimate of 42.00 and a low estimate of 14.00.Alethia Young's average stock forecast success ratio is 55.63% with an ... NKTX Nkarta NEXI MRNS STML STOK Stoke Therapeutics THRX VSTM Verastem LBPH. Show ...Since the start of the year, NKTX lost 77% of its equity value. However, in sharp contrast to the market performance, analysts rate NKTX a unanimous strong buy. Their average price target lands at ...Cell therapy developer Nkarta, Inc. ( NASDAQ: NKTX) fell ~34% on Tuesday as Wall Street reacted to updated data from its Phase 1 trial for lead candidate NKX101 in patients with relapsed or ...On today's stock market, the biotech stock soared 140.9% to 18.72. After the close, Nkarta announced a public offering for $150 million shares of its common stock.Dec 1, 2023 · In 2022, GSK plc's revenue was 29.32 billion, an increase of 18.74% compared to the previous year's 24.70 billion. Earnings were 14.96 billion, an increase of 241.07%. Financial numbers in GBP Financial Statements. Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $68.19M. -89.4%. Market Cap / Employee. The market cap of a ...Here’s how equities historically perform in the week after Thanksgiving as markets shift to holiday season. Nov. 27, 2023 at 12:40 p.m. ET by Christine Idzelis. Stock market barrels into year ...Nkarta has generated ($2.50) earnings per share over the last year ( ($2.50) diluted earnings per share). Earnings for Nkarta are expected to grow in the coming year, from ($2.50) to ($2.42) per share. Nkarta has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 21st, 2024 ... IOBT Stock 12 Months Forecast. $9.00. (837.99% Upside) Based on 3 Wall Street analysts offering 12 month price targets for IO Biotech in the last 3 months. The average price target is $9.00 with a high forecast of $10.00 and a low forecast of $8.00. The average price target represents a 837.99% change from the last price of $0.96.

Reed's, Inc. (NYSE:REED) posted its quarterly earnings data on Thursday, November, 9th. The company reported ($0.34) earnings per share for the quarter, topping the consensus estimate of ($0.40) by $0.06. The business had revenue of $11.86 million for the quarter, compared to analysts' expectations of $15.38 million.Oct 2, 2023 · NKTX Stock Predictions, Articles, and Nkarta Inc News ... NKTX stock is a fast mover, and a recent share-price bump came in the wake of exciting data from a "killer cell" anti-cancer research program. Nkarta Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NKTX updated stock price target summary. ... Stock Price Target NKTX. High $ 25.00: Median $ 14.00: Low $ 9.00 ...Instagram:https://instagram. after hour stock marketqqqy stock dividendcfd trading usahow to trade after hours on robinhood (NKTX) reported a total revenue of $25 million. The company's net income for ... As of 2023, the company's stock price is $45 per share. When analyzing the ... top mortgage lenders in virginiawine stock News Nkarta Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-2.50 Market Cap $128.57 M Shares Outstanding 49.07 M … best stock sites Company Summary. Nkarta Inc. is a biopharmaceutical company. It develops and commercializes cell therapies for cancer treatment. The company's product candidate includes NKX101 and NKX019, which ...CRISPR Therapeutics (NASDAQ: CRSP) and Nkarta (NASDAQ: NKTX) aim to develop CRISPR/Cas9 gene-edited cell therapies for cancer. Under a new collaboration, the two companies will develop and ...Dec 2, 2023 · The consensus price target of analysts on Wall Street is $14.13, which implies an increase of 80.75% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $9.00 and $25.00 respectively. As a result, NKTX is trading at a discount of -819.12% off the target high and -230.88% off the low.